ARTICLE | Company News
EMA accepts ospemifene MAA for review
March 28, 2013 12:13 AM UTC
Shionogi & Co. Ltd. (Tokyo:4507; Osaka:4507) said EMA accepted for review an MAA for ospemifene to treat postmenopausal vulvovaginal atrophy. Shionogi has exclusive, worldwide rights, excluding undisc...